Christopher Pasquale
Stock Analyst at Barclays
(4.32)
# 1,347
Out of 5,043 analysts
157
Total ratings
61.1%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Christopher Pasquale
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVR Anteris Technologies Global | Initiated Coverage: Hold | $17 → $10 | $6.77 | +47.71% | 2 | Oct 7, 2026 | |
| BAX Baxter International | Initiated Coverage: Sell | $27 → $20 | $24.35 | -17.86% | 5 | Oct 7, 2026 | |
| BDX Becton, Dickinson and Company | Initiated Coverage: Sell | $204 → $165 | $183.75 | -10.20% | 3 | Oct 7, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $24 | $17.30 | +38.73% | 1 | Oct 7, 2026 | |
| BSX Boston Scientific | Initiated Coverage: Hold | $85 → $48 | $42.73 | +12.33% | 16 | Oct 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $64 → $115 | $84.11 | +36.73% | 12 | Oct 7, 2026 | |
| GEHC GE HealthCare Technologies | Initiated Coverage: Buy | $86 → $85 | $65.74 | +29.30% | 2 | Oct 7, 2026 | |
| HUMA Humacyte | Initiated Coverage: Hold | $3.5 → $0.5 | $0.4053 | +23.37% | 2 | Oct 7, 2026 | |
| ISRG Intuitive Surgical | Initiated Coverage: Buy | $485 | $423.96 | +14.40% | 1 | Oct 7, 2026 | |
| LIVN LivaNova | Initiated Coverage: Buy | $105 | $76.39 | +37.45% | 1 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $198 → $150 | $135.28 | +10.88% | 9 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $10 | $8.98 | +11.36% | 5 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $240 → $375 | $277.33 | +35.22% | 13 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $18 | $16.11 | +11.73% | 6 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $145 → $100 | $89.14 | +12.18% | 12 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $55 | $36.13 | +52.23% | 4 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $17.63 | +70.16% | 1 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | CHF 58.25 | CHF 53.14 | +9.62% | 3 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $98 → $60 | $54.37 | +10.35% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $65 | $68.89 | -5.65% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $120 → $95 | $88.48 | +7.37% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $19.71 | +11.62% | 1 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $30 | $18.40 | +63.04% | 5 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $77.87 | +54.10% | 1 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $305 | $319.40 | n/a | 2 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $90 | $85.21 | n/a | 8 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 4 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $99.60 | n/a | 13 | Jan 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $34.04 | n/a | 1 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $85 | $22.44 | n/a | 4 | Nov 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $80 | $13.44 | n/a | 1 | Jul 31, 2015 |
Anteris Technologies Global
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $17 → $10
Current: $6.77
Upside: +47.71%
Baxter International
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $27 → $20
Current: $24.35
Upside: -17.86%
Becton, Dickinson and Company
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $204 → $165
Current: $183.75
Upside: -10.20%
Bausch + Lomb
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $17.30
Upside: +38.73%
Boston Scientific
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $85 → $48
Current: $42.73
Upside: +12.33%
DexCom
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $64 → $115
Current: $84.11
Upside: +36.73%
GE HealthCare Technologies
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $86 → $85
Current: $65.74
Upside: +29.30%
Humacyte
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $3.5 → $0.5
Current: $0.4053
Upside: +23.37%
Intuitive Surgical
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $485
Current: $423.96
Upside: +14.40%
LivaNova
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $105
Current: $76.39
Upside: +37.45%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $198 → $150
Current: $135.28
Upside: +10.88%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $30 → $10
Current: $8.98
Upside: +11.36%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $240 → $375
Current: $277.33
Upside: +35.22%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $14 → $18
Current: $16.11
Upside: +11.73%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $145 → $100
Current: $89.14
Upside: +12.18%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $21 → $55
Current: $36.13
Upside: +52.23%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $17.63
Upside: +70.16%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: CHF 58.25
Current: CHF 53.14
Upside: +9.62%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $98 → $60
Current: $54.37
Upside: +10.35%
Oct 6, 2026
Initiated Coverage: Sell
Price Target: $65
Current: $68.89
Upside: -5.65%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $88.48
Upside: +7.37%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $22
Current: $19.71
Upside: +11.62%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $50 → $30
Current: $18.40
Upside: +63.04%
Oct 6, 2026
Initiated Coverage: Buy
Price Target: $120
Current: $77.87
Upside: +54.10%
Jul 30, 2025
Upgraded: Buy
Price Target: $305
Current: $319.40
Upside: n/a
Jul 21, 2025
Upgraded: Buy
Price Target: $90
Current: $85.21
Upside: n/a
May 7, 2021
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Jan 2, 2020
Downgraded: Hold
Price Target: n/a
Current: $99.60
Upside: n/a
Nov 6, 2019
Reiterated: Buy
Price Target: $150
Current: $34.04
Upside: n/a
Nov 5, 2018
Reiterated: Buy
Price Target: $57 → $85
Current: $22.44
Upside: n/a
Jul 31, 2015
Upgraded: Buy
Price Target: $80
Current: $13.44
Upside: n/a